Glucuronate salt of a piperazine compound

Details for Australian Patent Application No. 2006291058 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Ali, Kadum; Shah, Syed Muzafar; Mirmehrabi, Mahmoud; Fawzi, Mahdi B.; Diorio, Christopher R.; Ehrnsperger, Eric C.; Deshmukh, Subodh S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006291058

PCT Pub. Number WO2007/033191

Priority 60/716,167 12.09.05 US

Filing date 12 September 2006

Wipo publication date 22 March 2007

Acceptance publication date 8 September 2011

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/538 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/033191 Priority application(s): WO2007/033191

3 July 2008 Assignment before Grant

  Wyeth The application has been assigned to Solvay Pharmaceuticals B.V.

8 September 2011 Application Accepted

  Published as AU-B-2006291058

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006291059-Salicylate and gentisate salts of a piperazine compound

2006291054-Recurrent gene fusions in prostate cancer